Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jvalini Dwarkasing"'
Autor:
Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, Heike Niessner, Ulrike Leiter, Ulrike Keim, Andrea Forschner, Jvalini Dwarkasing, Félicia Tjien-Fooh, Renske Wever, Lukas Flatz, Alexander Eggermont, Stephan Forchhammer
Publikováno v:
European Journal of Cancer. 182:155-162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87c51d489fd719ea10bc80df07660870
https://doi.org/10.1016/j.ejca.2022.12.021
https://doi.org/10.1016/j.ejca.2022.12.021
Autor:
Viengneesee Thao, Ruchita Dholakia, James P. Moriarty, Bijan J. Borah, Jvalini Dwarkasing, Alexander Meves
Publikováno v:
International journal of dermatologyReferences. 62(1)
The Merlin assay for melanoma-risk assessment has become commercially available to reduce the rate of unnecessary sentinel lymph node biopsies (SLNB) in SLNB-eligible patients with cutaneous melanoma. Merlin low-risk patients are recommended to under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d90e46c1431db8d0fdca09aa27555f0
https://pubmed.ncbi.nlm.nih.gov/36440797
https://pubmed.ncbi.nlm.nih.gov/36440797
Autor:
Evalyn Mulder, Iva Johansson, Dirk Grünhagen, Dennie Tempel, Barbara Rentroia-Pacheco, Jvalini Dwarkasing, Daniëlle Verver, Antien Mooyaart, Astrid van der Veldt, Tamar Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes Hollestein, Roger Olofsson Bagge
Publikováno v:
European Journal of Surgical Oncology. 49:e33-e34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bad890e1bf7090ec6e44af6632f1135
https://doi.org/10.1016/j.ejso.2022.11.138
https://doi.org/10.1016/j.ejso.2022.11.138
Autor:
teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, Heike Niessner, Ulrike Leiter, Ulrike Keim, Andrea Forschner, Jvalini Dwarkasing, Félicia Tjien-Fooh, Renske Wever, Lukas Flatz, Alexander M.M. Eggermont, Stephan Forchhammer
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42e16caf9526cab32cea1d308e8bf09d
https://doi.org/10.2139/ssrn.4267710
https://doi.org/10.2139/ssrn.4267710
Autor:
Teresa Maria Santos Amaral, Tobias Sinnberg, Eftychia Chatziioannou, Heike Niessner, Ulrike M. Leiter, Ulrike Keim, Andrea Forschner, Jvalini Dwarkasing, Lisette Meerstein-Kessel, Thomas Rademaker, Renske Wever, Alexander M. Eggermont, Lukas Flatz, Stephan Forchhammer
Publikováno v:
Journal of Clinical Oncology. 40:9564-9564
9564 Background: AJCC v8 includes Breslow thickness and ulceration to subdivide stage I and II CM pts into risk groups. In light of the results from adjuvant therapy in stage II CM, it has been discussed that pts’ follow-up and eventually treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c259461a70c1015a31debe6ff2e943c
https://doi.org/10.1200/jco.2022.40.16_suppl.9564
https://doi.org/10.1200/jco.2022.40.16_suppl.9564
Autor:
Evert M. van Schothorst, Renger F. Witkamp, Jvalini Dwarkasing, Hans J. M. Swarts, Rogier L. C. Plas, Frans van Gemerden, Miranda van der Ende, Miriam van Dijk, Attusa Sarokhani, Sander Grefte, Klaske van Norren
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports 11 (2021)
Scientific Reports, 11
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports 11 (2021)
Scientific Reports, 11
Targeted exercise combined with nutritional and pharmacological strategies is commonly considered to be the most optimal strategy to reduce the development and progression of cachexia. For COPD patients, this multi-targeted treatment has shown benefi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb1a7130ac05e66e4f828b4a1828b626
https://pubmed.ncbi.nlm.nih.gov/34732809
https://pubmed.ncbi.nlm.nih.gov/34732809
Autor:
Lisette Meerstein-Kessel, Alexander M.M. Eggermont, Alexander Meves, Jvalini Dwarkasing, Domenico Bellomo
Publikováno v:
European Journal of Cancer. 157:518-519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fffac96e9b4ede8edd5ca4308dc01e
https://doi.org/10.1016/j.ejca.2021.08.042
https://doi.org/10.1016/j.ejca.2021.08.042
Autor:
Sindhuja Sominidi-Damodaran, Alexander M.M. Eggermont, Mark A. Cappel, Dennis H. Murphree, Renske Wever, Barbara Rentroia‐Pacheco, Julia S. Lehman, Charles Perniciaro, Mark R. Pittelkow, Tina J. Hieken, Martin H. van Vliet, Félicia J. Tjien-Fooh, Enrica Quattrocchi, Domenico Bellomo, Alina G. Bridges, Sanjay P. Bagaria, Alexander Meves, Suzette M. Arias-Mejias, Jason C. Sluzevich, James W. Jakub, Jvalini Dwarkasing
Publikováno v:
Eur J Cancer
PURPOSE: Patients with stage I/IIA cutaneous melanoma (CM) are currently not eligible for adjuvant therapies despite uncertainty in relapse risk. Here, we studied the ability of a recently developed model which combines clinicopathologic and gene exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9484cf16f28617c4fe49c365c8522fe4
https://pubmed.ncbi.nlm.nih.gov/34565669
https://pubmed.ncbi.nlm.nih.gov/34565669
Autor:
Enrica Quattrocchi, Dennis H. Murphree, Sandra Gjorgova Gjeorgjievski, Mark Luna‐Vargas, Jeff Chen, Dennie Tempel, Alina G. Bridges, Alexander Meves, Suzette M. Arias-Mejias, Julia S. Lehman, Jvalini Dwarkasing
Publikováno v:
International Journal of Dermatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e53b82dffa985989887056dad4943c
https://pubmed.ncbi.nlm.nih.gov/32516450
https://pubmed.ncbi.nlm.nih.gov/32516450
Autor:
Tina J. Hieken, Sindhuja Sominidi-Damodaran, Barbara A. Pockaj, Jason C. Sluzevich, David J. DiCaudo, Charles Perniciaro, Alina G. Bridges, Joel B. Heim, Enrica Quattrocchi, Martin H. van Vliet, Mark R. Pittelkow, James W. Jakub, Sanjay P. Bagaria, Félicia J. Tjien-Fooh, Julia S. Lehman, Mark A. Cappel, Alexander Meves, Suzette M. Arias-Mejias, Domenico Bellomo, Jvalini Dwarkasing, Chandru Ramana
Publikováno v:
JCO Precis Oncol
PURPOSE More than 80% of patients who undergo sentinel lymph node (SLN) biopsy have no nodal metastasis. Here, we describe a model that combines clinicopathologic and molecular variables to identify patients with thin- and intermediate-thickness mela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::852a99bd01a0b0f58c6676b051769856
https://europepmc.org/articles/PMC7220172/
https://europepmc.org/articles/PMC7220172/
